Document Detail


Pharmacological manipulation of peripheral resistance during distal vascular reconstruction.
MedLine Citation:
PMID:  1382323     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A randomised placebo-controlled trial was conducted to investigate the effects of iloprost, a stable prostacyclin analogue, on peripheral resistance, during femoro-crural arterial bypass. 3000 ng of iloprost, infused into the graft, produced an immediate drop in peripheral resistance by a mean (range) of 43% (4-80%; p less than 0.01, Wilcoxon). Decreased peripheral resistance persisted to 20 minutes. Graft flow during the same period increased by 59.8% (-7 to 294%; p less than 0.01) and this increase persisted after the operation. Iloprost produces an immediate decrease in peripheral resistance associated with a prolonged increase in graft blood flow. This may reduce graft failure in the early postoperative period.
Authors:
F C Smith; C P Shearman
Related Documents :
3490333 - Comparison of perioperative and postoperative phasic blood flow in aortocoronary venous...
10424373 - Comparative of blood flow to the ankle-brachial index after iliac angioplasty.
22294473 - C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  VASA. Supplementum     Volume:  36     ISSN:  0251-1029     ISO Abbreviation:  Vasa Suppl     Publication Date:  1992  
Date Detail:
Created Date:  1992-10-22     Completed Date:  1992-10-22     Revised Date:  2008-02-21    
Medline Journal Info:
Nlm Unique ID:  8704474     Medline TA:  Vasa Suppl     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  55-7     Citation Subset:  IM    
Affiliation:
University Department of Vascular Surgery, Queen Elizabeth Hospital, Birmingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Blood Flow Velocity / physiology
Combined Modality Therapy
Female
Foot / blood supply*
Graft Occlusion, Vascular / physiopathology
Humans
Iloprost / administration & dosage*
Ischemia / physiopathology,  surgery*
Male
Middle Aged
Saphenous Vein / transplantation*
Vascular Resistance / drug effects*,  physiology
Chemical
Reg. No./Substance:
78919-13-8/Iloprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of mepartricin on the growth of hypertrophic prostatic tissue in primary culture. Creation o...
Next Document:  Dimethylnitrosamine (DMN)-induced IL-1 beta, TNF-alpha, and IL-6 inflammatory cytokine expression.